Clinical Trials
2 trialsNCT06564623 2026-05-08
Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Recruiting
NCT00995358 2009-10-15
A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer
University of Yamanashi
Phase 2 Unknown